IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot showdown: can a new HPV vaccine match the gold standard?
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether a single dose of the CERVAVAC HPV vaccine works as well as a single dose of the Gardasil vaccine. About 1,266 girls and boys aged 9 to 20 in Zambia will receive one shot and be followed for two years. Researchers will compare immune responses to see if CE…
Matched conditions: IMMUNOGENICITY
Phase: PHASE4 • Sponsor: International Agency for Research on Cancer • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:01 UTC
-
New eye injection for Diabetes-Related vision loss enters safety testing
Disease control Not yet recruitingThis early-stage study tests whether a single eye injection of PRO-169 is safe for people with diabetic macular edema, a condition that causes vision loss in diabetes. The main focus is checking if the body makes antibodies against the drug, which could reduce its effectiveness. …
Matched conditions: IMMUNOGENICITY
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated May 17, 2026 04:16 UTC